Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL1405517 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TDP1LMNATRPA1SLC15A2 | |
| SCHEMBL100425 | 0.97 | — | — | |
| Water SCHEMBL6432972 | 0.94 | ALDH1A1 (0.50) | ALDH1A1TDP1LMNATRPA1SLC15A2 | |
| Methyl Alcohol SCHEMBL6420552 | 0.94 | — | — | |
| Methylene Chloride SCHEMBL7695098 | 0.91 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL4304807 | 0.91 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL3630221 | 0.91 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL1395290 | 0.91 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL861591 | 0.91 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL5133360 | 0.91 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110130376-A1 | NEW NO RELEASING STEROIDS DERIVATIVES | NICOX S.A. (FR) | 2011-06-02 | — | — | US | disclosed |
| EP-2321334-A1 | NEW NO RELEASING STEROIDS DERIVATIVES | Nicox S.A. (FR) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010015529-A1 | NEW NO RELEASING STEROIDS DERIVATIVES | NICOX S.A. (FR) | 2010-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110130376-A1 | NEW NO RELEASING STEROIDS DERIVATIVES | CYP11B2, CYP11B1, NR3C2 | ALDH1A1 1473/4885TDP1 3310/4885LMNA 3571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.